Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Bio Products Laboratory Ltd., Elstree, WD6 3BX, United Kingdom
Human Varicella-Zoster Immunoglobulin 100 IU/ml solution for injection.
Pharmaceutical Form |
---|
Solution for injection. The colour can vary from a colourless to pale yellow sterile solution (see section 6.6). |
Human varicella-zoster immunoglobulin.
Human protein content 40-180 g/l of which at least 95% is IgG.
Each vial contains 250mg human varicella-zoster immunoglobulin.
One ml contains 100 IU/ml human varicella immunoglobulin.
The maximum IgA content is 540 micrograms/ml.
Distribution of the IgG subclasses (approximate values):
IgG1 64.3%
IgG2 29.0%
IgG3 6.2%
IgG4 0.5%
Produced from the plasma of human donors.
Excipient with known effect:
Sodium content: This medicinal product contains not more than 10 mg (0.5 mmol) sodium per 250 mg therefore it is essentially ‘sodium-free’.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Human varicela zoster immunoglobulin |
Human varicella zoster immunoglobulin contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against varicella-zoster virus. It is used for prophylaxis against varicella zoster virus (VZV) infection. |
List of Excipients |
---|
Sodium chloride |
5 ml glass vial (Type I Ph.Eur.) closed with a halobutyl stopper and over-sealed with a tamper-evident cap.
Vials are for single use only.
Pack size:
Human Varicella-Zoster Immunoglobulin 100 IU/ml solution for injection.
1 × 250 mg vial.
Bio Products Laboratory Ltd., Elstree, WD6 3BX, United Kingdom
PL 08801/0013
Date of first authorisation: November 1991
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.